Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus

Virology Journal

Volumn 7, Issue 1, 2010, Pages

  Zhang, Zhenhua ^a,b   Li, Yongqing ^b   Xu, Shufang ^b   Chen, Fuyong ^a   Zhang, Li ^b   Jiang, Beiyu ^b   Chen, Xiaoling ^b  

^a INSTITUTE OF PLANT AND ENVIRONMENT PROTECTION   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3D PROTEIN M2 FUSION PROTEIN; DNA VACCINE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PLASMID DNA; PROTEIN M2; PROTEIN M2 ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE; COMPLEMENT COMPONENT C3D; INFLUENZA VACCINE; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA (H9N2); CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; INFLUENZA A VIRUS (H9N2); LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VACCINE IMMUNOGENICITY; ANIMAL; BAGG ALBINO MOUSE; BIRD DISEASE; BLOOD; CELL LINE; GENETICS; GERMFREE ANIMAL; HAMSTER; IMMUNOLOGY; INFLUENZA VIRUS A; MOLECULAR GENETICS; RANDOMIZATION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CHICKENS; COMPLEMENT C3D; CRICETINAE; IMMUNITY, HUMORAL; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; POULTRY DISEASES; RANDOM ALLOCATION; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL MATRIX PROTEINS;

EID: 77951948072     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-89     Document Type: Article

References (44)

1. Nielsen CH, Fischer EM, Leslie RG: The role of complement in the acquired immune response. J Immunol 2000, 100:4-12.
2. Rus H, Cudrici C, Niculescu F: The role of the complement system in innate immunity. Immunol Res 2005, 33:103-12.
3. Thornton BP, Vetvicka V, Ross GD: Natural antibody and complementmediated antigen processing and presentation by B lymphocytes. J Immunol 1994, 152:1727-1737.
4. Sahu A, Sunyer JO, Moore WT, Sarrias MR, Soulika AM, Lambris JD: Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunol Res 1998, 17:109-121.
5. Sun-HL Jae UJ, Robert EM: Complementing viral infection: mechanisms for evading innate immunity. Trends in Microbiology 2003, 11:449-452.
6. Thornton BP, Vetvicka V, Ross GD: Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 1996, 104:531-537.
7. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271:348-350.
8. Lou D, Kohler H: Enhanced molecular mimicry of CEA using photoaffinity cross-linked C3d peptide. Nature Biotechnology 1998, 16:458-462.
9. Ross TM, Xu Y, Bright RA, Robinson HL: C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nature Immunol 2000, 1:127-131.
10. Anderson R, Gao XM, Papakonstantinopoulou A, Fairweather N, Roberts M, Dougan G: Immunization of mice with DNA encoding fragment C of tetanus toxin. Vaccine 1997, 15:827-829.
11. Bower J F, Sanders K L, Ross T M: C3d Enhances Immune Responses Using Low Doses of DNA Expressing the HIV-1 Envelope from Codon-Optimized Gene Sequences. Curr HIV Res 2005, 3:191-198.
12. Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL: Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination with gp120-C3d Fusion Proteins. AIDS Res Hum Retroviruses 2001, 617:829-835.
13. Wang L, Oriol Sunyer J, Bello LJ: Immunogenicity of a bovine viral diarrhea virus E2-C3d fusion protein containing a bovine homolog of C3d. Developmental and comparative immunology 2005, 29:907-915.
14. Liu D, Niu ZX: Cloning of a gene fragment encoding chicken complement component C3d with expression and immunogenicity of Newcastle disease virus F gene-C3d fusion protein. Avian Pathol 2008, 37:477-485.
15. Logan GJ, Wang L, Zheng M, Coppel RL, Alexander IE: Antigen fusion with C3d3 augments or inhibits humoral immunity to AAV genetic vaccines in a transgene-dependent manner. Immunol Cell Biol 2010, 88:228-32.
16. Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ: Protection of mice against influenza A virus challenge by vaccination with baculovirus expressed M2 protein. Vaccine 1995, 13:1399-1402.
17. Frace AM, Klimov AI, Rowe T, Black RA, Katz JM: Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 1999, 17:2237-2244.
18. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5:1157-1163.
19. Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, Zheng BJ, Zhou Y: An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J 2010, 18:7-9.
20. Rao SS, Kong WP, Wei CJ, Van Hoeven N, Gorres JP, Nason M, Andersen H, Tumpey TM, Nabel GJ: Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS One 2010, 5:e9812.
21. Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos L Jr, Gerhard W: Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003, 21:2616-2626.
22. Nauta AJ, Roos A, Daha MR: A regulatory role for complement in innate immunity and autoimmunity. Int Arch Allergy Immunol 2004, 134:310-323.
23. Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF: Cutting edge: C3d function as a molecular adjuvant in absence of CD21/35 expression. J Immunol 2004, 172:5833-5839.
24. Carter RH, Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256:105-107.
25. Hess MW, Schwendinger MG, Eskelinen EL, Pfaller K, Pavelka M, Dierich MP, Prodinger WM: Tracing uptake of C3dg-conjugated antigen in B cells via complement receptor type 2 (CR2, CD21). Blood 2000, 95:2617-2623.
26. Cherukuri A, Cheng PC, Pierce SK: The role of the CD19/CD21 complex in B cell processing and presentation of complement: Tagged antigen. J Immunol 2001, 167:163-172.
27. Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF: Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement. J Immunol 2005, 75:8011-8023.
28. Green TD, Montefiori DC, Ross TM: Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol 2003, 77:2046-2055.
29. Mitchell JA, Green TD, Bright RA, Ross TM: Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003, 21:902-914.
30. Green TD, Newton BR, Rota PA, Xu Y, Robinson HL, Ross TM: C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 2002, 20:242-248.
31. Henson SE, Smith D, Boackle SA, Holers VM, Karp DR: Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J Immunol Methods 2001, 258:97-107.
32. Frinklln R, Ross TM: Mouse strain-dependent differences in enhancement of immune response by C3d. Vaccine 2004, 22:1773-1778.
33. Suradhat S, Braun RP, Lewis PJ, Babiuk LA, Hurk S van Drunen Littel-van den, Griebel PJ, Baca-Estrada ME: Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1glycoprotein D inhibits immune responses following DNA immunization. J Vet Immunol 2001, 83:79-92.
34. Bower JF, Yang X, Sodroski J, Ross TM: Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated C3d. J virol 2004, 78:4710-4719.
35. Green TD, Montefiori DC, Ross TM: Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d. J Virol 2003, 77:2046-2055.
36. Roberts T, Snow EC: Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J Immunol 1999, 162:4377-4380.
37. Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ: Mapping of the receptor (CR2) binding site and antigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci 1985, 82:4235-4239.
38. Hellwage J, Jokiranta TS, Friese MA, Wolk TU, Kampen E, Zipfel PF, Meri S: Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol 2002, 169:6935-6942.
39. Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S: Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gpl20 glycoprotein by codon optimization and C3d fusion in a mouse mode1. Vaccine 2004, 22:1764-1772.
40. Mitsuyoshi JK, Hu Y, Test ST: Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide. Infect Immun 2005, 73:7311-7316.
41. Bower JF, Sanders KL, Ross TM: C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codonoptimized gene sequences. Curr HIV Res 2005, 3:191-198.
42. Zhang ZH, Zhou XM, Chen NH, Chen XL, Luo CB, Li YQ: Cloning and Structural Analysis of Chicken Complement Component C3d Gene. J Biotechnology Letter 2006, 17:267-270. [In Chinese].
43. Li YQ, Yao SX, Wei L, Yang HC: Deletion of coding sequence of transmembrane domain of M2 protein of Avian Influenza virus. Chinese Journal of Veterinary Medicine 2004, 40:6-9. [In Chinese].
44. Li YQ, Yang J, Wei L, Yang HC: Expression of Avian Influenza Virus M2 Gene in E. coli and Analysis of its antigenicity. Acta Veterinaria et Zootechnica Sinica 2005, 36:739-743. [In Chinese]. doi: 10.1186/1743-422X-7-89